StockData
CollPlant Biotechnologies Ltd logo

CollPlant Biotechnologies Ltd (OPHI) stock

OPHINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as CLGN
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30
$3.40−0.20 (-5.56%)

Close on Nov 18, 2026Market cap $4.91MP/E –Yield –

CollPlant Biotechnologies operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$11.48M. The highest annual figure on record is $65.00K in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.48M–
FY2024Dec 31, 2024-$17.25M–
FY2023Dec 31, 2023-$7.51M–
FY2022Dec 31, 2022-$17.10M-26403.1%
FY2021Dec 31, 2021$65.00K–
FY2020Dec 31, 2020-$5.60M–
FY2019Dec 31, 2019-$7.63M–
FY2018Dec 31, 2018-$4.25M–
FY2017Dec 31, 2017-$5.96M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2025Jun 30, 2025-$3.18M–
Q2 FY2024Jun 30, 2024-$4.41M–
Q2 FY2023Jun 30, 2023$5.68M–
Q2 FY2022Jun 30, 2022-$4.19M–
Q2 FY2021Jun 30, 2021-$3.06M–
Q2 FY2020Jun 30, 2020-$1.91M–
Q2 FY2019Jun 30, 2019-$1.76M–
Q2 FY2018Jun 30, 2018-$1.39M–

More CollPlant Biotechnologies figures

See a number that looks wrong?